Who Buys Tobramycin from India — 580 Importers Behind a $39.2M Market

The 580 buyers of Tobramycin imported from India can be categorized into several segments:

• Distributors: Entities like LIFESTAR PHARMA LLC and EVERSANA LIFE SCIENCE SERVICES in the United States fall into this category. They purchase large volumes to supply hospitals, pharmacies, and other healthcare providers. Their buying behavior is characterized by bulk orders and a focus on maintaining a consistent supply chain to meet market demand.

• Contract Manufacturers: Companies such as SUN PHARMACEUTICAL INDUSTRIES INC. in the United States are contract manufacturers. They procure Tobramycin to produce finished pharmaceutical products, either for their own brands or on behalf of other companies. Their procurement patterns are aligned with production schedules and client demands, often involving large, periodic orders.

• Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM serve as intermediaries, importing Tobramycin for redistribution to other markets. Their purchasing behavior is influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

• Government Procurement Agencies: While not explicitly listed among the top 10 buyers, government agencies in various countries procure Tobramycin through tenders to supply public healthcare facilities. Their buying patterns are typically characterized by large, infrequent orders based on national healthcare needs and budget allocations.

Understanding the import regulations for Tobramycin in the top five importing countries is crucial for market entry and compliance:

The demand for Tobramycin across various countries is driven by several factors:

• Disease Prevalence: Tobramycin is primarily used to treat severe bacterial infections, including those caused by Pseudomonas aeruginosa, which is prevalent in hospital-acquired infections. The global rise in antibiotic-resistant infections has increased the reliance on aminoglycosides like Tobramycin.

• Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of effective antibiotics. For instance, the WHO's AWaRe classification system, updated in 2019, categorizes antibiotics to guide appropriate use, with Tobramycin listed in the 'Watch' category, indicating its importance in treating specific infections. (who.int)

• Universal Health Coverage Expansion: Countries expanding their healthcare coverage are increasing access to essential medicines, including antibiotics. This expansion leads to higher demand for medications like Tobramycin to treat bacterial infections.

• WHO Essential Medicines List Procurement: Tobramycin's inclusion in the WHO Model List of Essential Medicines underscores its critical role in healthcare. This designation encourages countries to prioritize its procurement to ensure availability in public health systems. (who.int)

• Tender-Based Purchasing: Many governments and international organizations procure medicines through tenders to ensure cost-effectiveness and supply security. The WHO's guidelines on good pharmaceutical procurement practices emphasize transparent and efficient tendering processes, which influence the purchasing patterns for antibiotics like Tobramycin. (iris.who.int)

With 580 buyers across 134 countries, the global market for Tobramycin imported from India is substantial. The repeat buyer rate of 51.7% indicates a stable demand, presenting opportunities for exporters to establish long-term relationships and expand their market presence.

The 580 buyers of Tobramycin imported from India can be categorized into several segments:

• Distributors: Entities like LIFESTAR PHARMA LLC and EVERSANA LIFE SCIENCE SERVICES in the United States fall into this category. They purchase large volumes to supply hospitals, pharmacies, and other healthcare providers. Their buying behavior is characterized by bulk orders and a focus on maintaining a consistent supply chain to meet market demand.

• Contract Manufacturers: Companies such as SUN PHARMACEUTICAL INDUSTRIES INC. in the United States are contract manufacturers. They procure Tobramycin to produce finished pharmaceutical products, either for their own brands or on behalf of other companies. Their procurement patterns are aligned with production schedules and client demands, often involving large, periodic orders.

• Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM serve as intermediaries, importing Tobramycin for redistribution to other markets. Their purchasing behavior is influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

• Government Procurement Agencies: While not explicitly listed among the top 10 buyers, government agencies in various countries procure Tobramycin through tenders to supply public healthcare facilities. Their buying patterns are typically characterized by large, infrequent orders based on national healthcare needs and budget allocations.

Understanding the import regulations for Tobramycin in the top five importing countries is crucial for market entry and compliance:

The demand for Tobramycin across various countries is driven by several factors:

• Disease Prevalence: Tobramycin is primarily used to treat severe bacterial infections, including those caused by Pseudomonas aeruginosa, which is prevalent in hospital-acquired infections. The global rise in antibiotic-resistant infections has increased the reliance on aminoglycosides like Tobramycin.

• Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of effective antibiotics. For instance, the WHO's AWaRe classification system, updated in 2019, categorizes antibiotics to guide appropriate use, with Tobramycin listed in the 'Watch' category, indicating its importance in treating specific infections. (who.int)

• Universal Health Coverage Expansion: Countries expanding their healthcare coverage are increasing access to essential medicines, including antibiotics. This expansion leads to higher demand for medications like Tobramycin to treat bacterial infections.

• WHO Essential Medicines List Procurement: Tobramycin's inclusion in the WHO Model List of Essential Medicines underscores its critical role in healthcare. This designation encourages countries to prioritize its procurement to ensure availability in public health systems. (who.int)

• Tender-Based Purchasing: Many governments and international organizations procure medicines through tenders to ensure cost-effectiveness and supply security. The WHO's guidelines on good pharmaceutical procurement practices emphasize transparent and efficient tendering processes, which influence the purchasing patterns for antibiotics like Tobramycin. (iris.who.int)

With 580 buyers across 134 countries, the global market for Tobramycin imported from India is substantial. The repeat buyer rate of 51.7% indicates a stable demand, presenting opportunities for exporters to establish long-term relationships and expand their market presence.